INDUCTION OF RENAL-CELL CARCINOMA IN MALE CD-1 MICE FOLLOWING CHRONIC ADMINISTRATION OF 2,4-DINITROTOLUENE

被引：0
|
作者：
HONG, CB [1 ]
ELLIS, HV [1 ]
LEE, CC [1 ]
SPRINZ, H [1 ]
机构：
[1] MIDWEST RES INST,KANSAS CITY,MO 64110
来源：
FEDERATION PROCEEDINGS | 1980年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：882 / 882
页数：1
相关论文
共 50 条
  • [31] THE MANAGEMENT OF ISOLATED RENAL RECURRENCE OF RENAL-CELL CARCINOMA FOLLOWING COMPLETE RESPONSE TO INTERLEUKIN-2 BASED IMMUNOTHERAPY
    LONG, JP
    WALTHER, MM
    ALEXANDER, RB
    LINEHAN, WM
    ROSENBERG, SA
    JOURNAL OF UROLOGY, 1993, 150 (01): : 176 - 178
  • [32] Trabecular and cortical bone are unaltered in response to chronic lipopolysaccharide exposure via osmotic pumps in male and female CD-1 mice
    Bott, Kirsten N.
    Yumol, Jenalyn L.
    Comelli, Elena M.
    Klentrou, Panagiota
    Peters, Sandra J.
    Ward, Wendy E.
    PLOS ONE, 2021, 16 (02):
  • [33] SURGICAL RESECTION FOLLOWING INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA PROLONGS REMISSION
    KIM, B
    LOUIE, AC
    ARCHIVES OF SURGERY, 1992, 127 (11) : 1343 - 1349
  • [34] Investigation of hepatic cytochrome P-450 enzyme induction and DNA adduct formation in male CD/1 mice following oral administration of toxaphene
    Hedli, CC
    Snyder, R
    Kinoshita, FK
    Steinberg, M
    JOURNAL OF APPLIED TOXICOLOGY, 1998, 18 (03) : 173 - 178
  • [35] EFFECT OF PENTACHLOROPHENOL ON THE ACTIVATION OF 2,6-DINITROTOLUENE TO GENOTOXIC URINARY METABOLITES IN CD-1 MICE - A COMPARISON OF GI ENZYME-ACTIVITIES AND URINE MUTAGENICITY
    GEORGE, SE
    CHADWICK, RW
    CREASON, JP
    KOHAN, MJ
    DEKKER, JP
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1991, 18 (02) : 92 - 101
  • [36] Short-term administration of 17-β estradiol to outbred male CD-1 mice induces changes in the immune system, but not in reproductive organs
    Karpuzoglu-Sahin, E
    Gogal, RM
    Hardy, C
    Sponenberg, R
    Ahmed, SA
    IMMUNOLOGICAL INVESTIGATIONS, 2005, 34 (01) : 1 - 26
  • [37] SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED RENAL-CELL CARCINOMA - A CONFIRMATORY STUDY
    FACENDOLA, G
    LOCATELLI, MC
    PIZZOCARO, G
    PIVA, L
    PEGORARO, C
    PALLAVICINI, EB
    SIGNAROLDI, A
    MEREGALLI, M
    LOMBARDI, F
    BERETTA, GD
    SCANZI, F
    LABIANCA, R
    LUPORINI, G
    BRITISH JOURNAL OF CANCER, 1995, 72 (06) : 1531 - 1535
  • [38] INDUCTION OF TUMOR-CELL LYSIS BY BI-SPECIFIC MONOCLONAL-ANTIBODIES RECOGNIZING RENAL-CELL CARCINOMA AND CD3 ANTIGEN
    VANDIJK, J
    WARNAAR, SO
    VANEENDENBURG, JDH
    THIENPONT, M
    BRAAKMAN, E
    BOOT, JHA
    FLEUREN, GJ
    BOLHUIS, RLH
    INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (02) : 344 - 349
  • [39] CLINICAL AND BIOLOGICAL RESPONSES FOLLOWING INTERLEUKIN-2 THERAPY IN PATIENTS WITH METASTATIC MELANOMA AND RENAL-CELL CARCINOMA
    DORREEN, MS
    SHERIDAN, E
    SREENIVASAN, T
    HAYAT, K
    ROGERS, S
    BRUCE, L
    HANCOCK, BW
    CHAPMAN, K
    REES, RC
    BRITISH JOURNAL OF CANCER, 1991, 63 (05) : 833 - 834
  • [40] REGRESSION OF METASTATIC RENAL-CELL CARCINOMA FOLLOWING ADMINISTRATION OF PERIODATE-LYMPHOKINE ACTIVATED AUTOLOGOUS LEUKOCYTES AND LOW-DOSE RECOMBINANT INTERLEUKIN-2
    WANG, J
    WALLE, A
    GORDON, B
    NOVOGRODSKY, A
    SUTHANTHIRAN, M
    RUBIN, AL
    STENZEL, KH
    CLINICAL RESEARCH, 1987, 35 (03): : A529 - A529
12345